Overactive Bladder

Trends in Overactive Bladder Therapy: Associations Between Clinical Care Pathways, Practice Guidelines, and Therapy Utilization Patterns. November 22, 2024

The Association between Depression and Overactive Bladder: A Cross-Sectional Study of NHANES 2011-2018. November 22, 2024

Spontaneous Resolution of Post-COVID-19-Associated Sacral Neuromodulation Device Dysfunction and Overactive Bladder Symptoms: A Report of Two Cases. November 22, 2024

Urodynamic findings and vibegron effects on neurogenic lower urinary tract dysfunction caused by human T-cell leukemia virus type I-associated myelopathy/tropical spastic paraparesis. November 22, 2024

Predictive Factors for Clean Intermittent Catheterization after Intravesical OnabotulinumtoxinA Injections in Women with Overactive Bladder: a Danish Retrospective Cohort Study. November 15, 2024

A pilot study on the potential of photobiomodulation to safely modify symptoms of an overactive bladder. November 15, 2024

Efficacy of the combination of transcutaneous tibial nerve stimulation and mirabegron in women with overactive bladder in a prospective randomized controlled trial. November 15, 2024

The association between education level and overactive bladder: Evidence from a U.S. population-based study. November 10, 2024

Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey. November 10, 2024

Sacral and Implantable Tibial Neuromodulation for the Management of Overactive Bladder: A Systematic Review and Meta-analysis. November 3, 2024

Effect of standard urotherapy to children with overactive bladder on quality of life. November 3, 2024

Unilateral and Bilateral Transcutaneous Tibial Nerve Stimulation in Women With Overactive Bladder Syndrome: A Randomized Controlled Study (UBTTNS-OAB Study). November 3, 2024

Efficacy of high-dose vitamin D supplementation vs. solifenacin or standard urotherapy for overactive bladder dry in children: a secondary analysis of a randomized clinical trial. October 24, 2024

The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature. October 24, 2024

Screening of overactive bladder syndrome and its relation with insomnia: A public health experience. October 24, 2024

Variation in Overactive Bladder Treatment Type by Social Determinants of Health October 21, 2024

Urethral Bulking Agents for the Treatment of Urinary Incontinence: Efficacy, Safety, and Impact on the Overactive Bladder Symptoms with an Underlying Detrusor Overactivity. October 20, 2024

Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade after Approval: A Single-Blind Study to Evaluate the Reduction in Pain in OnabotulinumtoxinA Detrusor Injection Using Different Injection Needles. October 20, 2024

The Management of Children and Adolescents with Overactive Bladder Refractory to Treatment with Parasacral Transcutaneous Electrical Nerve Stimulation. October 18, 2024

Sexual Dysfunction in Patients with Overactive Bladder Syndrome Treated with Botulinum Toxin. October 18, 2024

Page 1 of 122